Tower Research Capital (TRC)’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $145K | Buy |
6,669
+5,676
| +572% | +$124K | ﹤0.01% | 2075 |
|
|
2025
Q1 | $18.4K | Sell |
993
-606
| -38% | -$11.2K | ﹤0.01% | 3048 |
|
|
2024
Q4 | $42.6K | Buy |
1,599
+1,416
| +774% | +$37.7K | ﹤0.01% | 2655 |
|
|
2024
Q3 | $4.3K | Sell |
183
-1,309
| -88% | -$30.8K | ﹤0.01% | 4597 |
|
|
2024
Q2 | $27.7K | Buy |
1,492
+888
| +147% | +$16.5K | ﹤0.01% | 3549 |
|
|
2024
Q1 | $10.8K | Buy |
+604
| New | +$10.8K | ﹤0.01% | 3651 |
|